Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
Expert Review of Pharmacoeconomics & Outcomes Research|August 13, 2025
Preference research is underutilized in health preventionBrett Hauber, Mickael HiligsmannExpert Review of Pharmacoeconomics & Outcomes Research|September 2, 2017
The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in FranceMickael Hiligsmann, Jean-Yves ReginsterExpert Review of Pharmacoeconomics & Outcomes Research|July 24, 2025
The economic benefits of fracture preventionLakshmi Nagendra, Manju Chandran, Mickael HiligsmannTherapeutic Innovation & Regulatory Science|January 3, 2024
Pediatric Market Access: A Qualitative StudyLieke Maas, Angelika Joos, Mickael HiligsmannExpert Review of Pharmacoeconomics & Outcomes Research|June 17, 2009
Healthy-years equivalent: wounded but not yet deadA Brett HauberJournal of Managed Care & Specialty Pharmacy|February 28, 2020
The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of OsteoporosisMickael Hiligsmann, Jean-Yves Reginster, Stuart SilvermanFrontiers in Medical Technology|January 20, 2022
A Digital Innovation for the Personalized Management of Adherence: Analysis of Strengths, Weaknesses, Opportunities, and ThreatsAnna-Elisa Hein, Bernard Vrijens, Mickael HiligsmannApplied Health Economics and Health Policy|September 22, 2019
Using the Threshold Technique to Elicit Patient Preferences: An Introduction to the Method and an Overview of Existing Empirical ApplicationsBrett Hauber, Joshua CoulterExpert Review of Pharmacoeconomics & Outcomes Research|August 14, 2024
Burden of non-motor symptoms of Parkinson's disease: cost-of-illness and quality-of-life estimates through a scoping reviewFrank van der Meer, Jesper Jorgensen, Mickael HiligsmannJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 21, 2012
Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic womenMickael Hiligsmann, Wafa Ben Sedrine, Jean-Yves ReginsterPageof 24